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Background and purpose: The Medical Physics Division of the Portuguese Physics Society (DFM_SPF) in
collaboration with the IAEA, carried out a national auditing project in radiotherapy, between September
2011 and April 2012. The objective of this audit was to ensure the optimal usage of treatment planning
systems. The national results are presented in this paper.
Material and methods: The audit methodology simulated all steps of external beam radiotherapy work-
ﬂow, from image acquisition to treatment planning and dose delivery. A thorax CIRS phantom lend by
IAEAwas used in 8 planning test-cases for photon beams corresponding to 15 measuring points (33 point
dose results, including individual ﬁelds in multi-ﬁeld test cases and 5 sum results) in different phantom
materials covering a set of typical clinical delivery techniques in 3D Conformal Radiotherapy.
Results: All 24 radiotherapy centers in Portugal have participated. 50 photon beams with energies 4
e18 MV have been audited using 25 linear accelerators and 32 calculation algorithms.
In general a very good consistency was observed for the same type of algorithm in all centres and for
each beam quality.x: þ351 239 484317.
saude.pt, mdcarmolopes@
Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.
M.C. Lopes et al. / Physica Medica 30 (2014) 96e103 97Conclusions: The overall results conﬁrmed that the national status of TPS calculations and dose delivery
for 3D conformal radiotherapy is generally acceptable with no major causes for concern. This project
contributed to the strengthening of the cooperation between the centres and professionals, paving the
way to further national collaborations.
 2013 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.Introduction
According to accident and incident international reporting da-
tabases in radiotherapy, treatment planning system (TPS) related
occurrences are among the main sources of errors [1].
In line with its long history in dosimetry auditing, the Interna-
tional Atomic Energy Agency (IAEA) promoted the present project
on TPS audit with the purpose of ensuring improved and safer
practices in radiotherapy.
The details of the project design were published by the IAEA.
The comprehensive IAEA document on acceptance testing,
commissioning and QA of TPSs, published as Technical Reports
Series No. 430 [2], was further focused on dose computation veri-
ﬁcation tests to meet the practical needs of common users namely
in small hospitals with reduced staff [3].
In the present version the test-cases cover a range of typical
delivery techniques in three-dimensional conformal radiotherapy
(3D-CRT) with photon beams that have been chosen for TPS
commissioning according to the recommendations of IAEA.
After a pilot study to test the audit design [4], the Baltic States,
Hungary, Serbia [5], Slovakia and Poland have conducted national
TPS audits with the IAEA assistance, before Portugal has done it [6].
The adopted methodology uses an anthropomorphic phantom
e CIRS thorax 002 LFC (CIRS Inc., Norfolk, Virginia) e and follows
the radiation treatment sequential steps from image acquisition to
treatment delivery, including image transfer and planning process,
in an end-to-end approach.
According to the proposed methodology the DFM_SPF was
recognized as the national auditing organization in Portugal. The na-
tional coordinator traveled through all 24 RT centres with the phan-
tom to carry out the audit between November 2011 and April 2012.
The project implementation phases included: i) Individual
centres application in a volunteer basis e September and October
2011; ii) First round of the audit through the 24 participating
centres: performance of two phantom scans (the ﬁrst one for CT to
RED (relative electron density) conversion purposes and the second
one for planning the test cases) e November and December 2011;
iii) Second round of the audit: performance of the audit measure-
ments in each centre after that centre had calculated the test cases
plans for the different energies and algorithms used in its clinical
practice e January e March 2012. The irradiation of the test cases
started with a dose intercomparison between the dosimetric
reference system of the pilot centre and the local one; iv) Finally the
evaluation workshop took place in June for the presentation of the
national results and global discussion.Materials and methods
National characterization
Portugal is thewesternmost country in Europe and includes also
as national territory the Atlantic archipelagos of the Azores and
Madeira. The present population is around 10.5 million, oddly
distributed among the 18 administrative districts [7]. In fact, if we
add to the two more important metropolitan areas of Lisbon and
Porto four other western coast districts we will sum up almost 70%
of the population. In both insular territories there are less than0.5 million people. In terms of radiotherapy health care, the rec-
ommended ratio of 5e6 linear accelerators per million inhabitants
would imply an installed park of around 60 treatment units.
As of April 2012, there were 44 linear accelerators installed in
Portugal, including 2 units in Madeira and none in Azores. They
pertain to 24 radiotherapy centres. 8 out of these 24 centres are
public hospitals and own 18 of these linacs. The other 16 are private
RT centres with one or two machines, each owning the remaining
26 treatment units. The installed treatment units park covers more
than 70% of the national needs but the geographical distribution is
not optimal [8]. During the audit project a questionnaire also pro-
posed by the IAEAwas answered by all RT centres about the typical
characteristics of RT treatments and we concluded that at present
more than 80% of the radiotherapy treatments offered to patients in
Portugal can be classiﬁed as 3D-CRT treatments.
All 24 RT centres have volunteered to participate in the audit
project. Due to logistic reasons it was decided that just one linear
accelerator would be involved in the audit in each centre. The total
number of linear accelerators used in the audit was 25 out of 44
because in one centre 2 linacs have been used. From the 25 linacs
used in the audit, 15 are Varian machines, 6 Elekta and 4 Siemens.
More than 90% of the linacs are less than 10 years old. The oldest
unit was installed in the year 2000.
The 25 linacs corresponded to 50 high energy photon beams
distributed as follows according to the nominal energy: 4 MV(1);
6 MV(24); 10 MV(6); 15 MV(14); 16 MV(2) and 18 MV(3). Just
photon energies have been tested in the audit.
25 TPSs have been audited grouped from three main commer-
cial names: 14 Eclipse (Varian); 9 XiO (CMS/Elekta) and 2 Oncentra
(Nucletron/Elekta), corresponding to 32 tested algorithms. They
have been grouped according to broad types for volume scatter
integration and heterogeneity modeling without the reference to
the particular version in each case. Thus we have labeled PB (Pencil
Beam) those models that ignore the lateral transport of electrons
and where inhomogeneity corrections are primarily based on the
equivalent path length. Two TPSs have this kind of algorithm e
Eclipse (from Varian) in 9 of the participating centres and Oncentra
(from Nucletron/Elekta) in 2 centres. The other algorithms e Ana-
lytic Anisotropic Algorithm, AAA (in Eclipse) in 9 centres; Super-
position and Fast Superposition (in XiO/Elekta) in 7 centres and
Collapsed Cone, CC (in Oncentra) in 1 centre e correspond to
models that in some extent incorporate the lateral transport of
electrons. These two kinds of models will be further referred in this
work as Type A and Type B algorithms, respectively, following the
terminology used in Ref. [9].Audit phases
Pilot centre audit
The pilot centre was audited with the presence of the IAEA
expert. Two scans of the CIRS phantom have been done in the local
CT-scanner (Somaton Sensation Open, from Siemens), according to
the IAEA methodology. After the planning of the 8 test cases, the
corresponding irradiations for 6 and 15 MV in an Oncor Avant-
Garde from Siemens linac have been performed.
Before the irradiations, a dose comparison has been done be-
tween the IAEA calibrated ionization chamber and the local
Figure 1. Representation of the central slice of the CIRS phantom with location and
corresponding labels for the dose measuring points. The phantom materials corre-
spond to: points 1e5, plastic water; points 6e9, lung and point 10, bone.
Table 2
List of the objectives of the 8 test-cases including the labels of the 10 measuring
points.
Test
case
Measuring
points
Test objectives
1 3, 9, 10 Testing for reference ﬁeld based on CT data
2 1 Oblique incidence, wedge, lack of scattering
and tangential ﬁelds
3 3 Signiﬁcant blocking of the ﬁeld corners
4 5, 6, 10 Four ﬁeld box; dose per incidence; coach absorption
5 2, 7 Automatic expansion and customized blocking
6 3, 7, 10 Oblique incidence with irregular ﬁeld and blocking
the centre of the ﬁeld
7 5 Three ﬁelds, two wedge-paired, asymmetric collimation
8 5 Non coplanar beams with couch and collimator rotation
Table 3
Labels for the 33 dose results and corresponding agreement criteria.
Case/Point/Field Label of dose results Agreement criteria (%)
C1.P3 1 2
C1.P9 2 4
C1.P10 3 3
C2.P1 4 3
C3.P3 5 3
C4.P5.F1 6 2
C4.P5.F2 7 3
C4.P5.F3 8 3
C4.P5.F4 9 3
C4.P5.SUM 10 3
C4.P6.F1 11 4
C4.P6.F2 12 3
C4.P6.F3 13 4
C4.P6.F4 14 3
C4.P6.SUM 15 4
C4.P10.F1 16 3
C4.P10.F2 17 3
C4.P10.F3 18 3
C4.P10.F4 19 4
C4.P10.SUM 20 3
C5.P2 21 3
C5.P7 22 4
M.C. Lopes et al. / Physica Medica 30 (2014) 96e10398dosimetric reference system (in the sense of IAEA TRS 398 [10]),
composed by a Farmer type chamber (30013 e 0046, PTW-
Freiburg) and a UNIDOS 10370 electrometer also from PTW, Frei-
burg. For this comparison the point 3 in Test Case 1 has been used
(see Fig. 1). This corresponds to a setup of SSD ¼ 100 cm and a
10  10 cm2 ﬁeld size with point 3 at 7 cm depth and located in
a homogeneous region of plastic water within the CIRS phantom.
This dose comparison aimed at verifying the dose calibration ac-
curacy of the pilot reference dosimetric system in order to enable
its assignment as the national dosimetric reference within this
project.
CT scans of the CIRS phantom
The IAEAmethodology included two scans of the CIRS phantom.
For the ﬁrst scan 6 holes in the phantomwere ﬁlledwith 6 inserts of
reference materials corresponding to the known relative electron
densities (RED), as given in Table 1. A seventh holewas left empty to
correspond to air, in the lung phantom region.
For the second scan of the phantom all the standard inserts have
been placed in the corresponding holes. This second scan consti-
tuted the basis for planning the test cases.
The relationship between the CT-numbers (read in the CT-
scanner monitor) and the REDs was compared with the conver-
sion curve CT-to-RED included in the TPS. The acceptance criterion
was 20 HU according to Ref. [2]. This constituted one of the non-
dosimetric tests. The other non-dosimetric test was made in order
to check the accuracy of the measurement distances before and
after the image transfer from the CT-scanner to the TPS, and also
after plotting the central phantom slice.
Irradiation of the test cases
As it was mentioned above, the TPS audit in Portugal was con-
ducted by the national coordinator including two rounds through
the participating centres. After the ﬁrst round (where the CT scans
have been performed) each centre was given sufﬁcient time for
planning the eight test cases summarized in Table 2, in terms of
each test objectives. Figure 1 shows a representation of the centralTable 1
Relative electron densities of reference materials inserts for the CIRS phantom.
Insert material Relative electron density
Lung substitute 0.207
Adipose substitute 0.949
Water (a syringe ﬁlled with water) 1
Muscle substitute 1.042
Bone substitute 1.506
Dense bone substitute 2.005slice of the CIRS phantom where the locations and corresponding
labels of the ten possible insertion points for the ionization
chamber are presented. The adopted agreement criterion for each
point dose was derived from TRS-430 [2] with the normalization to
the reference dose point for each test case, according to:
D½% ¼ 100*ðDcal  DmeasÞ=Dmeas;ref (1)
where Dmeas, Dcal and Dmeas,ref are respectively the measured dose,
the TPS calculated dose and the dose value measured at the refer-
ence point speciﬁed for each test case. The need for reference point
is dictated by the limited number of measurements points available
in CIRS phantom (this is to follow TECDOC 1540 [11] for estimation
of deviations). The agreement criteria take into account the
complexity of test cases and varied from 2% for the calibration test
case (Test Case 1, point 3) to 5% for Test Case 6 corresponding to
measurements in lung in the penumbra region (point 7) and in
bone below ﬁeld blocks (point 10). All 33 dose results are labeled in
Table 3 where the corresponding agreement criteria are presented.C6.P3 23 3
C6.P7 24 5
C6.P10 25 5
C7.P5.F1 26 2
C7.P5.F2 27 4
C7.P5.F3 28 4
C7.P5.SUM 29 3
C8.P5.F1 30 3
C8.P5.F2 31 3
C8.P5.F3 32 3
C8.P5.SUM 33 3
Figure 2. Total scatter correction factors (Sc,p) for 6 MV in Varian linear accelerators.
The reference data was provided by the IAEA and corresponds to measurements on 5
Varian HE accelerators produced between 2006 and 2011 and averaged. The error bars
correspond to 3% tolerance from reference values for each ﬁeld size. All 14 centres
with this type of linac and beam energy have calculated Sc,p for the same ﬁeld sizes and
using the speciﬁed setup (Sc,p at SAD ¼ 100 cm, 10 cm depth in water).
Figure 3. 60 wedge factor (WF) for 15 MV in Elekta linear accelerators. The reference
data was provided by the IAEA and corresponds to measurements on 5 Elekta accel-
erators produced between 2007 and 2010 and averaged. The error bars correspond to
3% tolerance from reference values for each ﬁeld size. All 5 centres with this type of
linac and beam energy have calculated WF for the same ﬁeld sizes and using the
speciﬁed setup (WF at SSD ¼ 100 cm, 10 cm depth in water).
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water cavities within the various inserts in order to derive the
absorbed dose to water from ionization chamber measurements.
The agreement criteria also include the difference between
perturbation factors caused by the ion chamber in these materials
relative to that of water.
Each centre was given an option to use one or more algorithms
included in the local TPS(s) depending on the clinical routine. Any
doubts and questions have been addressed in an open collaboration
with the national coordinator, during the planning stage.
Apart from the 8 test cases also some benchmark input data
(according to the Radiological Physics Center (RPC) standard data
acceptation [12e14]) supplied by the IAEA for each linac make and
energy, namely wedge factors (WF) and total scatter correction fac-
tors (Sc,p) for a wide range of ﬁeld sizes corresponding to reference
setups in water have been taken as the reference. These input data
corresponded tomeasurements on 5 Varian HE, 5 Elekta Synergy and
5 Siemens Primus accelerators produced between 2006 and 2011 and
averaged for each accelerator type. These setups could be reproduced
in the TPSs and the calculated input beamparameters comparedwith
the reference input data for each beam quality.
In each centre the irradiationswere always preceded by the dose
comparison between the reference dosimetric system of the pilot
centre and the local reference system for the beam qualities to be
audited. Point 3 of Test-Case 1 was used for this dose comparison.
The dosimetric daily quality control tests results have not been
taken into account. Nevertheless all centres have reported that they
werewithin tolerance (2e3%dependingon the centre) in the audit day.
Results
Dose comparison
The dose comparison between the reference dosimetric system
from the pilot centre and the one from the IAEA expert was within
0.2% for 6 and 15 MV beams. This result conferred the status of na-
tional reference for the dosimetric audit to the reference dosimetric
system from the pilot centre that has then traveled around the
participating centreswhere the audit started by the dose comparison
with the local reference dosimetric system. All 50 beam dose cali-
brations were within 1.5 and 2.2% (average of 0.14  0.8%) when
compared with the pilot centre measurement (Test Case 1, point 3).
Different types of ionization chambers e 11 Farmer type chambers
from PTW; 5 Farmer type chambers from IBA and 8 small thimble
chambers of 0.125 cc from PTW ewith corresponding electrometers
constituted the local reference system in each centre. 9 out of 24 of
the systems had a calibration certiﬁcate from the Portuguese SSDL, 6
have been calibrated at PTW, Freiburg and 3 in IBA laboratories. No
correlation was found with chamber type nor with the origin of the
calibration.
TPS input data check
Generally a very good consistency with the referred benchmark
data supplied by the IAEA was shown for all linac makes and beam
energies, concerning both output factors (Sc,p) and wedge factors
(WF). Someexceptionshavebeen investigated, explainedorcorrected.
In Fig. 2 the Sc,p are shown for 6 MV in Varian machines. Four-
teen centres have got this beam/machine combination and as it can
be seen the calculated Sc,p are all within the stipulated 3% toler-
ance from the reference data. The same pattern has been observed
for the other energies and linac makes. In Fig. 3 another example is
given, concerning 60 wedge factors (WF) for 15 MV in Elekta
machines. There were ﬁve centres with this beam/machine com-
bination. As it can be seen the results from two centres deviate fromtolerance when compared with the reference data. Nevertheless
the causes for the observed deviations were different. For centre 1
the dependence of WF with ﬁeld size is the same as for the refer-
ence data and it was concluded that the shift towards higher values
came from the physical characteristics of the 60-wedge in centre 1
that were different from the corresponding to the benchmark data.
In fact also for Varian machines similar differences have been
identiﬁed in two other participating centres where systematic de-
viations of 9.5% (for 15 WF) and 13.5% (for 30 WF) have been
observed and attributed to physical wedges corresponding to
different part numbers within Varian references.
The deviations observed in Fig. 3 for centre 20 were not
explained by that reason. The ﬂat behavior observed in the WFs in
15 MV has also been observed for the other energies (6 and 10 MV)
Figure 4. Comparison between the conversion curves CT-to-RED obtained in 2001 and
in the present audit (2011) together with the audit measurements for one of the
participating centres.
M.C. Lopes et al. / Physica Medica 30 (2014) 96e103100and in Sc,p values for this centre. It was concluded that the water
phantom used in the TPS for calculating these basic input data in
this centre was too small preventing the full lateral and back
scattering to be taken into account. The replacement of the virtual
water phantom by a larger one led to corrected values within
tolerance.Non-dosimetric tests
From the 24 CT scanners that entered the audit, most of them
were RT dedicated scanners. The majority of the centres used a
constant kVp value for the planning CTs and a customized CT to RED
curve. Nevertheless a general failure of CT to RED conversion has
been observed in bone (92% failures) and dense bone (75% failures)
which was probably due to the use of different reference materials
for CT calibration. The weak inﬂuence of this kind of deviations in
dose calculations was veriﬁed in one centre where a study with
different CT-to-RED curves has been performed, conﬁrming previ-
ous published results [15]. In Fig. 4 the audit measurements and
corresponding calibration curve (2011) are compared with the in-
ternal curve used in that centre since 2001 where a different CIRS
phantom model had been used for CT calibration. The deviations in
dense bone were justiﬁed by the extrapolation of the old curve in
the high density region. Also the different shapes, sizes and com-
positions of the two CIRS phantoms could contribute to the re-
ported deviations. Nevertheless dose differences of just up to 0.5%
were found when the dose distributions for Test-Case 4 (box
technique) were compared using the old and the new CT-to-RED
curves (in a 2D dose difference analysis). Despite the conﬁrmed
reduced inﬂuence in dose calculations, most centers have replacedTable 4
Distribution of the different algorithms and number of centres per beam energy, includi
Energy (mV) TPS algorithm (number of centres)
4 AAA_Ecla (1) PB_Ecl (1)
6 AAA_Ecl (9) PB_Ecl (9) Spos_XiOb
10 AAA_Ecl (1) Spos_XiO (
15 AAA_Ecl (5) PB_Ecl (6) Spos_XiO (
18 AAA_Ecl (2) PB_Ecl (1) Spos_XiO (
a Ecl ¼ Eclipse.
b Spos ¼ Superposition.
c F Spos ¼ Fast Superposition.
d Onc ¼ Oncentra.their internal conversion curves, using the new results obtained for
bone and dense bone.
The Oncentra (Nucletron/Elekta) TPS has a unique feature con-
cerning CT-to-RED conversion as it does not deal directly with
electron densities. In this TPS the CT Hounsﬁeld Units, or the
manually speciﬁed density, are mapped to a list of typical tissue
types. For each of these tissue types a lookup table exists containing
the elemental composition and parameters describing the radio-
logical properties for this elemental composition derived from Ref.
[16]. Should the HU value fall between two tissue types, then these
parameters will be interpolated. So for this TPS no possible curve
adjustment was possible.
Dosimetric tests
In total globally, 68 sets of algorithm-beam combination were
analyzed using the 8 test cases corresponding to 33 dose results for
each set, including individual ﬁelds in multi-ﬁeld test cases and 5
sum results. The results were grouped by beam energy and the type
of TPS algorithm as follows: 4 MV beam energy with 2 algorithms
and corresponding to 2 participating centres; 6 MV beam energy
with 6 algorithms and corresponding to 32 participating centres;
10 MV beam energy with 4 algorithms and corresponding to 8
participating centres; 15 MV beam energy with 6 algorithms and
corresponding to 21 participating centres; 18MV beam energywith
4 algorithms and corresponding to 5 participating centres. The
details of this distribution are shown in Table 4.
Each point dose result has been evaluated for all 68 algorithm-
beam combination sets. The larger number of failures per point
dose result considering all 68 algorithm-beam sets corresponded to
Test Case 4 (box technique) for individual incidences e measuring
point 6 (lung) for the right-lateral incidence had 28/68 dose results
out of the agreement criterion of 3% and for point 10 (bone) for
posterior incidence 22/68 measurements were recorded outside
the tolerance level of 3%. Fortunately, when the sum result for the
four incidences (box-technique) was computed for these points the
number of failures for individual ﬁelds almost canceled out (0 and 3
out of 68, respectively).
An interesting result from this kind of analysis is that the same
pattern could be observed for the same type of algorithm regardless
the participating centre, which gives good consistency to the
different algorithm implementations in the various sites. This
common pattern is documented in Fig. 5 where the results of Test
Case 4 in 6 MV for point 6 (lung) and left-lateral incidence are
presented. PB_Eclipse (Type A algorithm) failed by excess in 4
centres and AAA_Eclipse failed by default in all 9 centres together
with CC_Oncentra in one centre, both algorithms of Type B. In fact, a
positive deviation according to eq. (1) means that the TPS calcu-
lated dose value is higher than the measured dose, leading to
underdosage and vice-versa, a negative deviation means that the
delivered dose is higher than the desired dose, leading to an
overdosage. In Fig. 5 we can observe that all points correspondingng in total 68 algorithm-beam energy combination sets.
(8) F Spos_XiOc (3) PB_Oncd (2) CC_Onc (1)
6) F Spos_XiO (2) PB_Onc (1)
4) F Spos_XiO (1) PB_Onc (2) CC_Onc (1)
1) F Spos_XiO (1)
Figure 5. Results of the percentage deviations between measured and calculated doses, normalized to the measured dose in point 5 in each of the 24 centres, for left-lateral
incidence in point 6 (lung) and Test Case 4, for 6 MV. Different algorithms are represented by different symbols. Horizontal dashed lines represent the agreement criterion of
3% for this point dose.
Figure 6. Global deviations (averaged over the 68 algorithm-beam energy sets) for each dose point result labeled according to Table 3. The error bars designate the standard
deviation corresponding to each average deviation. The stars indicate the agreement criteria for each dose point.
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Table 5
Average deviations (D%) and corresponding standard deviations (s%) for the ﬁve worse dose points for three beam energy groups (4/6 MV, 10 MV and 15/18 MV) organized by
algorithm types (A and B). The number of sets per group is indicated in each case. The darker shadowingmeans worse results. The lighter shadowingmeans a marginal failure
(off the tolerance indicated for each dose point).
M.C. Lopes et al. / Physica Medica 30 (2014) 96e103102to Type A algorithms (including PB_Eclipse and PB_Oncentra) are
above the horizontal axis. For XiO algorithms (Superposition and
Fast Superposition), both of Type B, all points except one are above
the horizontal axis and all are within tolerance regardless the
participating centre, for this point dose result.
The measurements in bone (point 10, both in Test Case 1 and Test
Case 4) revealed a global trend to overdosage, meaning that all al-
gorithms calculated a lower dose than themeasured one. In Test Case
1 the average deviation in bone taking into account all 68 combina-
tion sets was1.5 1.4% and for the sum of all four beam incidences
in bone inTest Case 4 the average deviationwas1.31.3%. The dose
underprediction inside high-density materials for high-energy X-ray
beams is due to the fact that in general the dose calculation algo-
rithms cannot accurately model the increase of the interaction co-
efﬁcient inside the bone and only account for the decreased
transmission through the high-density medium [17].
Compatible (in the sense that the same tendency was observed)
but not directly comparable results (because the setups or purposes
are different) can be found in literature concerning dose calcu-
lations in low and high density heterogeneities with different
setups and both experimental and calculated arrangements [18,19].
A global picture of the results is given in Fig. 6 in terms of
average deviation over the 68 algorithm-beam energy sets and the
corresponding standard deviation for each point dose. For each
point also the agreement criterion is indicated, according to Table 3.
As it can be seen the overall results are good, meaning that the vast
majority of all bars are inside the agreement criteria limits.
Nevertheless, there are some algorithm-beam energy sets signiﬁ-
cantly out of tolerance for some dose points: in lung e C1.P9 (label
2), C4.P6.F3 (label 13), C4.P6.F4 (label 14) and C6.P7 (label 24), and
in bone e C4.P10.F3 (label 18). It is worthwhile to have a deeper
look into these deviations so they have been unfolded into low
energy (4 and 6 MV), medium energy (10 MV) and high energy (15
and 18 MV) groups and also by Type A and Type B algorithms.
The summary of these results is presented in Table 5. The
conclusionwas that Type A algorithms in all energies were the major
contributors for the larger deviations. Nevertheless, for the posterior
ﬁeld in bone (C4.P10.F3) Type B algorithms fail more. The shadowing
used in the table helps to realize that higher energies do worse than
lower ones, also in agreement with published results [17e19].
The Collapsed Cone algorithm in Oncentra TPS (CC_Oncentra)
deserves a speciﬁc mention because it is the algorithm that pre-
sented the higher number of failures, namely for 15 MV e 19 failures
over the 33 dose points results (in 6 MV, for CC algorithm just 8 dose
points failed). It must be stressed that the IAEA methodology was
developed for the systems which report dose to a water cavity insideamedium. CC algorithm inOncentra TPS reports dose tomedia so the
results would at least need a correction through the ratio of stopping
powers material/water which would imply the knowledge about the
atomic composition of the phantom materials to enable a more ac-
curate inclusion in the TPS internal conversion table.
Conclusions
The IAEA TPS audit project carried out in Portugal between
September 2011 and April 2012 had 100% of participation of the
radiotherapy centres in the country. It was an important initiative
to strengthening the scientiﬁc relationships among the medical
physics national community.
The overall results revealed that the national status of TPS cal-
culations and dose delivery for 3D conformal radiotherapy was
globally within acceptable standards with no major causes for
concern.
The dose comparison for the audited 50 photon beam energies
was remarkably good with an average value for the percentage
difference from pilot of 0.14  0.8% (min: 2.2% and máx: 1.5%).
In general, a very good consistency was observed for the same
type of algorithm in all centres and for each photon beam energy.
The known calculation limitations of TPS algorithms in heteroge-
neities have been conﬁrmed, namely for dose calculations in lung
and bone. From all 24 centres just 6 (25%) still uses just Type A
algorithms. Whenever more than one algorithm type is available at
the local TPS there is a general trend to gradually move to more
advanced algorithms in the clinical practice.
This tendency will probably be intensiﬁed as the present pattern
characterized by more than 80% of the RT treatments being clas-
siﬁed as 3D-CRT is rapidly changing towards more modern and
sophisticated techniques (IMRT, arc delivery techniques, stereotaxy,
etc.), which enhances the need for corresponding extension of this
kind of auditing project in a near future.
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